Portfolio (Quarterly)
Guide ↗
Deep Track Capital, LP
· CIK 0001856083| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | COAG | HEMAB THERAPEUTICS HLDGS INC | — | 3,602,093.0 | $132.3M | 1.93% | NEW | — | $36.73 | +44.0% |
| 22 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 4,200,000.0 | $131.3M | 1.91% | NEW | — | $31.26 | -19.5% |
| 23 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 2,750,000.0 | $129.4M | 1.88% | NEW | — | $47.04 | -3.1% |
| 24 | GRAL | GRAIL INC | Healthcare | 1,834,944.0 | $125.3M | 1.82% | NEW | — | $68.27 | +1.3% |
| 25 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 4,100,000.0 | $121.7M | 1.77% | NEW | — | $29.69 | -16.8% |
| 26 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 3,732,569.0 | $111.4M | 1.62% | NEW | — | $29.84 | -3.7% |
| 27 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 2,939,151.0 | $109.4M | 1.59% | NEW | — | $37.21 | +12.5% |
| 28 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 3,352,804.0 | $108.8M | 1.58% | NEW | — | $32.45 | +47.4% |
| 29 | MBX | MBX BIOSCIENCES INC | Healthcare | 1,732,569.0 | $95.6M | 1.39% | NEW | — | $55.20 | +20.0% |
| 30 | GHRS | GH RESEARCH PLC | Healthcare | 3,333,334.0 | $89.6M | 1.30% | NEW | — | $26.88 | +10.0% |
| 31 | GMAB CALL | GENMAB A/S | Healthcare | 3,000,000.0 | $82.4M | 1.20% | NEW | — | $27.47 | +19.8% |
| 32 | COGT | COGENT BIOSCIENCES INC | Healthcare | 2,000,000.0 | $77.4M | 1.13% | NEW | — | $38.70 | -3.0% |
| 33 | — | ATAIBECKLEY INC | — | 14,417,442.0 | $76.0M | 1.11% | NEW | — | $5.27 | — |
| 34 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 123,616.0 | $67.0M | 0.97% | NEW | — | $541.83 | -5.0% |
| 35 | — | AVALO THERAPEUTICS INC | — | 3,610,000.0 | $66.7M | 0.97% | NEW | — | $18.48 | — |
| 36 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 3,592,740.0 | $66.0M | 0.96% | NEW | — | $18.37 | +29.2% |
| 37 | CYTK | CYTOKINETICS INC | Healthcare | 700,000.0 | $59.6M | 0.87% | NEW | — | $85.19 | -11.1% |
| 38 | ALT | ALTIMMUNE INC | Healthcare | 19,250,000.0 | $58.5M | 0.85% | NEW | — | $3.04 | -1.8% |
| 39 | PSNL | PERSONALIS INC | Healthcare | 4,000,000.0 | $53.6M | 0.78% | NEW | — | $13.40 | +3.7% |
| 40 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 9,345,000.0 | $49.4M | 0.72% | NEW | — | $5.29 | +17.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Financial Services
0.4%